Similar articles for PMID: 21632453

Year	Number of Results
2003	1
2004	1
2006	1
2007	3
2008	6
2009	8
2010	5
2011	8
2012	16
2013	12
2014	15
2015	21
2016	6
2017	5
2018	7
2019	7
2020	5
2021	11
2022	4
2023	4
2024	0

1

Initial staging impact of fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced breast cancer.

Niikura N, Liu J, Costelloe CM, Palla SL, Madewell JE, Hayashi N, Yu TK, Tokuda Y, Theriault RL, Hortobagyi GN, Ueno NT. Niikura N, et al. Oncologist. 2011;16(6):772-82. doi: 10.1634/theoncologist.2010-0378. Epub 2011 May 31. Oncologist. 2011. PMID: 21632453 Free PMC article.

2

Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs.

Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A Jr, Ueno NT, Buchholz TA. Walker GV, et al. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1381-6. doi: 10.1016/j.ijrobp.2011.10.040. Epub 2012 Jan 26. Int J Radiat Oncol Biol Phys. 2012. PMID: 22284689

3

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Alberini JL, Lerebours F, Wartski M, Fourme E, Le Stanc E, Gontier E, Madar O, Cherel P, Pecking AP. Alberini JL, et al. Cancer. 2009 Nov 1;115(21):5038-47. doi: 10.1002/cncr.24534. Cancer. 2009. PMID: 19645022 Free article. Clinical Trial.

4

Discrepancy between FDG-PET/CT and contrast-enhanced CT in the staging of patients with inflammatory breast cancer: implications for treatment planning.

Jacene HA, DiPiro PJ, Bellon J, Hu J, Cheng SC, Warren L, Schlosnagle E, Nakhlis F, Rosenbluth JM, Yeh E, Overmoyer B. Jacene HA, et al. Breast Cancer Res Treat. 2020 Jun;181(2):383-390. doi: 10.1007/s10549-020-05631-4. Epub 2020 Apr 21. Breast Cancer Res Treat. 2020. PMID: 32318957

5

18F-FDG PET/CT in staging patients with locally advanced or inflammatory breast cancer: comparison to conventional staging.

Groheux D, Giacchetti S, Delord M, Hindié E, Vercellino L, Cuvier C, Toubert ME, Merlet P, Hennequin C, Espié M. Groheux D, et al. J Nucl Med. 2013 Jan;54(1):5-11. doi: 10.2967/jnumed.112.106864. Epub 2012 Dec 4. J Nucl Med. 2013. PMID: 23213197 Free article. Clinical Trial.

6

Baseline FDG PET-CT imaging is necessary for newly diagnosed inflammatory breast cancer patients: a narrative review.

Patel MM, Le-Petross HT. Patel MM, et al. Chin Clin Oncol. 2021 Dec;10(6):56. doi: 10.21037/cco-21-82. Epub 2021 Nov 16. Chin Clin Oncol. 2021. PMID: 34806397 Free article. Review.

7

Whole-body ¹⁸F-fluorodeoxyglucose positron emission tomography-computed tomography (¹⁸F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.

Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T. Gajjala SR, et al. Indian J Med Res. 2018 Mar;147(3):256-262. doi: 10.4103/ijmr.IJMR_1368_16. Indian J Med Res. 2018. PMID: 29923514 Free PMC article.

8

¹⁸F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations.

Cochet A, Dygai-Cochet I, Riedinger JM, Humbert O, Berriolo-Riedinger A, Toubeau M, Guiu S, Coutant C, Coudert B, Fumoleau P, Brunotte F. Cochet A, et al. Eur J Nucl Med Mol Imaging. 2014 Mar;41(3):428-37. doi: 10.1007/s00259-013-2595-4. Epub 2013 Nov 7. Eur J Nucl Med Mol Imaging. 2014. PMID: 24196916

9

Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.

Ng SP, David S, Alamgeer M, Ganju V. Ng SP, et al. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):111-7. doi: 10.1016/j.ijrobp.2015.05.012. Epub 2015 May 15. Int J Radiat Oncol Biol Phys. 2015. PMID: 26279029

10

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Riegger C, Herrmann J, Nagarajah J, Hecktor J, Kuemmel S, Otterbach F, Hahn S, Bockisch A, Lauenstein T, Antoch G, Heusner TA. Riegger C, et al. Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6. Eur J Nucl Med Mol Imaging. 2012. PMID: 22392069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year